Align Technology, Inc. (LON:0HCK)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 7.91B +8.0% |
| Revenue (ttm) | 3.12B +4.4% |
| Net Income | 311.71M -5.5% |
| EPS | 4.34 -2.8% |
| Shares Out | n/a |
| PE Ratio | 25.39 |
| Forward PE | 12.95 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 264 |
| Open | 152.01 |
| Previous Close | 152.79 |
| Day's Range | 148.41 - 154.97 |
| 52-Week Range | 122.19 - 200.37 |
| Beta | 1.64 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |
About Align Technology
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company’s Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. T... [Read more]
Financial Performance
In 2025, Align Technology's revenue was $4.03 billion, an increase of 0.90% compared to the previous year's $4.00 billion. Earnings were $410.35 million, a decrease of -2.61%.
Financial numbers in USD Financial StatementsNews
Align Technology to Speak at Upcoming Financial Conference
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, ...
Quentin Blackford to Join Align Technology Board of Directors
TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System ...
Align reports China judgement in its favor in patent infringement case
Align Technology (ALGN) announced that the Jinan Intermediate People’s Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology’s operating subs...
Align Technology Prevails in China Patent Infringement Action Against Angelalign
SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System ...
Align Technology Hosts 2026 Invisalign® Ortho Summit, Showcasing a “Beyond Possible” Vision for Connected Digital Orthodontics
LAS VEGAS & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners...
Align Technology to overhaul board following engagement with Elliott
Align Technology said on Wednesday it will add three new independent directors to its board and launch a review of its operations, following talks with activist investor Elliott Investment Managemen...
Align to appoint new independent directors, to repurchase $400M-$500M of shares
Align Technology (ALGN) announced several initiatives reflecting its commitment to strong corporate governance and shareholder value creation. Following discussions with Elliott Investment Management ...
Align Technology Announces Strategic Initiatives Consistent with Long-term Growth and Shareholder Value Creation Objectives
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, i...
Align Technology reports Q2 adjusted EPS $2.64, consensus $2.60
Reports Q2 revenue $1.056B, consensus $1.06B. Commenting on Align’s Q2’26 results, Align Technology (ALGN) President and CEO Joe Hogan said, “We delivered a solid second quarter with record revenues o...
Align Technology sees Q3 revenue $1B-$1.02B, consensus $1.02B
Sees Q3 adjusted gross margin roughly 71%. Sees Q3 adjusted operating margin roughly 24%.
Align Technology sees FY26 revenue growth 3%-4%
The company said, “Our full year 2026 revenue guidance continues to assume a benefit from foreign exchange that is consistent with the assumptions underlying our initial full year outlook. We…
Align Technology Announces Second Quarter 2026 Financial Results
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ int...
Align Technology Earnings Call Transcript: Q2 2026
Q2 2026 saw record revenues and clear aligner volumes, with strong international growth offsetting stable North America. Systems and services revenue declined due to a shift to lower-priced, flexible scanner models, but unit placements grew. Guidance calls for continued margin expansion and increased share repurchases.
Align Technology Earnings release: Q2 2026
Align Technology released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Align Technology Slides: Q2 2026
Align Technology has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
Align Technology Quarterly report: Q2 2026
Align Technology has published its Q2 2026 quarterly earnings report on July 29, 2026.
Align Technology Announces New Innovations to Advance Invisalign® Treatment Planning and Enhance Patient Engagement Through Its Integrated Align™ Digital Platform
TEMPE, Ariz & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear al...
Align Technology price target raised to $189 from $186 at UBS
UBS raised the firm’s price target on Align Technology (ALGN) to $189 from $186 and keeps a Neutral rating on the shares.
Operation Smile Announces Align Technology as Title Sponsor of 34th International Student Leadership Conference for Sixth Year
Over six years, Align has contributed more than $2M to Operation Smile's student programs to send the next generation of global health advocates to the world stage VIRGINIA BEACH, Va., and TEMPE, Ariz...
Align Technology initiated with an Outperform at BMO Capital
BMO Capital analyst Vik Chopra initiated coverage of Align Technology (ALGN) with an Outperform rating and $209 price target The stock is currently pricing in a prolonged market stagnation rather…
Align Technology to Announce Second Quarter 2026 Results on July 29, 2026
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intr...
Align says European Commission investigation ‘purely procedural’
Align Technology (ALGN) responded to the European Commission’s June 30 press release announcing an investigation involving the company based on a complaint made by an Align competitor. “Align Technolo...
Align Technology Statement on European Commission Proceeding
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, ...
Align Technology falls after EU opens formal antitrust investigation
Shares of Align Technology (ALGN) are moving lower after the European Commission said it has opened a formal antitrust investigation to assess whether the company breached European Union competition r...
EU case likely won’t have much fundamental impact on Align, says Leerink
Leerink reiterated an Outperform rating and $230 price target on Align Technology (ALGN), saying the firm’s understanding from precedent EU antitrust cases is that it could take 2-4 years between…